Bosses at nine of the world’s biggest pharmaceutical firms, including British giants GSK and AstraZeneca, say billions of pounds, jobs and cutting-edge treatments are heading to the US and China
Bosses at nine of the world’s biggest pharmaceutical firms, including British giants GSK and AstraZeneca, say billions of pounds, jobs and cutting-edge treatments are heading to the US and China